NAVCO Pharmaceuticals Inc. (TSXV:NAV)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
At close: Feb 9, 2026
NAVCO Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
570.70K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | - | - | - |
| Sep 30, 2024 | - | - | - |
| Sep 30, 2023 | - | - | - |
| Sep 30, 2022 | 58.73K | 43.21K | 278.32% |
| Sep 30, 2021 | 15.53K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayurcann Holdings | 31.28M |
| Vibe Growth | 22.19M |
| Adastra Holdings | 16.86M |
| Vencanna Ventures | 3.60M |
| Aequus Pharmaceuticals | 918.47K |
| Optimind Pharma | 131.48K |
| Global Health Clinics | 30.63K |
| Planet Based Foods Global | -356.97K |